Group a streptococcal infections in obstetrics and gynecology

Clinical Obstetrics and Gynecology

Volumn 55, Issue 4, 2012, Pages 864-874

  Rimawi, Bassam H ^a   Soper, David E ^a   Eschenbach, David A ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

fasciitis; group A streptococcus; necrotizing; postpartum endometritis; Streptococcus pyogenes; toxic shock syndrome

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; EXOTOXIN; INTERLEUKIN 2; INTERLEUKIN 8; M PROTEIN; PENICILLIN G; PROTEINASE; STREPTOCOCCAL CHEMOKINE PROTEASE; STREPTOCOCCUS PYOGENES EXOTOXIN A; STREPTOKINASE; STREPTOLYSIN O; STREPTOLYSIN S; T LYMPHOCYTE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; VANCOMYCIN;

ABORTION; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BLOOD CULTURE; CESAREAN SECTION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOMETRITIS; ENZYME DEGRADATION; EPIDEMIOLOGY; GROUP A STREPTOCOCCAL INFECTION; HEMATOCRIT; HEMOLYSIS; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INTENSIVE CARE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOPENIA; LIVE BIRTH; MATERNAL MORTALITY; METABOLIC ACIDOSIS; MICROBIOLOGY; NECROTIZING FASCIITIS; NEWBORN DEATH; OBESITY; PAIN; PREGNANCY; PUERPERIUM; SEPSIS; SEPTIC ABORTION; SEPTIC SHOCK; SOFT TISSUE INFECTION; STILLBIRTH; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; SURVIVAL; TOXIC SHOCK SYNDROME; VAGINA FLORA; VAGINAL DELIVERY; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; CELLULITIS; ENDOMETRITIS; FASCIITIS, NECROTIZING; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUERPERAL INFECTION; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURGICAL WOUND INFECTION; VAGINA; VIRULENCE FACTORS;

EID: 84868131586     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31827362fc     Document Type: Article

References (32)

1. O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United Sates, 2000-2004. Clin Infect Dis. 2007;45:853-862.
2. Davies HF, McGeer A, Schwartz B, et al. Ontario Groups A Streptococcal Study GroupInvasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;335:547-554.
3. Luca-Harari B, Ekelund K, van der Linden M, et al. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol. 2008;46:79-86.
4. Hanninen O, Farago M, Monos E. Ignaz Philipp Semmelweis, the prophet of bacteriology. Infection Control. 1983;4:367-370.
5. Kramer HM, Schutte JM, Zwart JJ, et al. Maternal mortality and severe morbidity from sepsis in the Netherlands. Acta Obstet Gynecol Scand. 2009;88:647-653.
6. Patterson MJ. Streptococcus In: Baron S, et al. ed. Baron's Medical Microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch; 1996.
7. Brown EJ. The molecular basis of streptococcal toxic shock syndrome. N Engl J Med. 2004;350: 2093-2094.
8. Bisno AL, Stevens DL. Streptococcus pyogenes. Chapter 198. Mendell's Textbook of Infectious Disease. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: 6th edition, Churchill Livingstone, PA; 2593-2610.
9. Ji Y, McLandsborough L, Kondagunta A, et al. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun. 1996;64:503-510.
10. Hidalgo-Grass C, Mishalian I, Dan-Goor M, et al. A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. EMBO J. 2006;25:4628-4637.
11. Deutscher M, Lewis M, Zell ER, et al. Incidence and severityof invasive Streptococcus pneumoniae, groupAStreptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011;53:114-123.
12. Deutscher M, Lewis M, Zell ER, et al. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011;53:114-123.
13. Martin JM, Green M, Barbadora KA, et al. Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics. 2004;114:1212-1219.
14. Schroeder BM. Diagnosis and management of group A streptococcal pharyngitis. Am Fam Physician. 2003;67:880, 883-884.
15. The Prevention of Invasive Group A Streptococcal Infections Workshop ParticipantsPrevention of invasive group A Streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the centers for Diseases Control and Prevention. Clin Infet Dis. 2002;35:950-959
16. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35:268-276.
17. Chuang I, Van Beneden C, Beall B et al and the ABCs/EIP Network. Population-based surveillance for postpartum invasive group A streptococcal infections, 1995-2000. Clin Infect Dis. 2002;35:665-670.
18. Aickin DR. Maternal mortality in New Zealand. N Z Med J. 1993;106:375-376.
19. Mead PB, Winn WC. Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol. 2000;8:217-219.
20. Stefonek KR, Maerz LL, Nielsen MP, et al. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. Obstet Gynecol. 2001;98 (pt 1):846-848.
21. Kaul R, McGeer A, Low DE, et al. Populationbased surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventyseven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18-24.
22. Schummer W, Schummer C. Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome. Infect Dis Obstet Gynecol. 2002;10: 217-222.
23. Stevens DL. Group A streptococcal sepsis. Curr Infect Dis Rep. 2003;5:379-386.
24. McGregor J, Ott A, Villard M. An epidemic of childbed fever. Am J Obstet Gynecol. 1984;150: 385-388.
25. Shy KK, Eschenbach DA. Fatal perineal cellulitis from an episiotomy site. Obstet Gynecol. 1979;54: 292-297.
26. Gryska PF, O'Dea AE. Postoperative streptococcal wound infection: the anatomy of an epidemic. JAMA. 1970;213:1189-1191.
27. Anaya Da, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:1436-1446.
28. Soper D. Early Recognition of Life-Threatening Infections. Monograph-American Congress of Obstetricians and Gynecologists. Available at: http://www. ACOG. org. Accessed October 1, 2012.
29. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18: 1096-1100.
30. Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis. 1984;149:471.
31. Norrby-Teglund A, Muller MP, Mcgeer A. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2005;37:166-172.
32. Kaul R,McGeer A, Norrby-Teglund A, et al. The Canadian Streptococcal Study GroupIntravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin Infect Dis. 1999;28:800-807.